The U.S. Food and Drug Administration (FDA) on Friday approved Biogen and Sage Therapeutics oral pill to treat postpartum depression (PPD) in…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Development
-
-
CompaniesPfizerRegulatoryU.S FDA
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for relapsed or Refractory Multiple Myeloma
by adminby adminPfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for…
-
GskWHO
WHO Grants Prequalification to GSK’s Mosquirix – the first and only approved Malaria Vaccine
by adminby adminSummary: The World Health Organization (WHO) has awarded prequalification to Mosquirix, GSK’s malaria vaccine. This is the first prequalification for a malaria vaccine…
-
CompaniesMerger / AcquisitionPfizer
Pfizer to Acquire Global Blood Therapeutics in $5.4bn Deal
by adminby adminSummary : Through the acquisition of Global Blood Therapeutics, Pfizer aims to enhance its presence in rare haematology and particularly sickle cell…
-
CompaniesCovid DrugsPfizer
Pfizer and BioNTech aubmit for U.S. Emergency Use Authorization of an additional booster dose of their COVID-19 vaccine for older adults
by adminby adminSummary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have submitted an application to the U.S. Food…
-
Pharma Science & Research
Bill & Melinda Gates Foundation launch initiative for future pandemics
by adminby adminSummary : The initiative will catalyse discovery and early development of antiviral medicines for future pandemics The Novo Nordisk Foundation, Open Philanthropy…
-
Pharma Science & ResearchRoche
Roche’s Vabysmo to offer ‘fierce competition’ to Regeneron’s Eylea
by adminby adminSummary : Roche’s Vabysmo is having a strong start with doctors, but it has a long way to go if it wants…
-
Sanofi Inc.
Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria
by adminby adminSummary : Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria In this Phase 3 trial, Dupixent…
-
Global Market
Syniverse Is First to Offer a Cloud-Native, Hyperscale Digital Communications and Messaging Platform for Enterprises: Syniverse’s Hyperscale Communications Platform
by adminby adminSummary : New Syniverse CPaaS Platform to Accelerate Enterprises’ Digital Transformation and Improve Customer Experience The Syniverse Hyperscale Communications Platform allows enterprises…
-
Covid DrugsGlobal MarketModernaPharma Science & Research
Moderna Projects COVID-19 Vaccine Sales at $19 Billion for 2022
by adminby adminSummary : Moderna only has a single marketed product, but it’s a blockbuster, for now at least. That product is the company’s…
Newer Posts